Results 11 to 20 of about 216,526 (119)
Background The systemic inflammatory response index (SIRI) is a novel inflammatory biomarker in many diseases. Objectives The aim of this study was to examine the association between SIRI and adverse events in patients with the acute coronary syndrome ...
K. Han+8 more
semanticscholar +1 more source
Background: Long-term outcomes of antiplatelet monotherapy in patients who receive percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis–Extended Antiplatelet Monotherapy ...
Jeehoon Kang+12 more
semanticscholar +1 more source
Antiplatelet therapy after percutaneous coronary intervention.
Antiplatelet therapy is key to reducing local thrombotic complications and systemic ischaemic events among patients undergoing percutaneous coronary interventions (PCI), but it is inevitably associated with increased bleeding.
D. Angiolillo+4 more
semanticscholar +1 more source
A growing number of patients undergoing percutaneous coronary intervention (PCI) with stent implantation also have atrial fibrillation. This poses challenges for their optimal antithrombotic management because patients with atrial fibrillation undergoing
D. Angiolillo+14 more
semanticscholar +1 more source
Calcium Modification Techniques in Complex Percutaneous Coronary Intervention
Supplemental Digital Content is available in the text. Percutaneous coronary intervention is the most common mode of revascularization and is increasingly undertaken in high-risk subsets, including the elderly.
M. Shah+3 more
semanticscholar +1 more source
Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention
Supplemental Digital Content is available in the text. Background: Vascular injury and inflammation during percutaneous coronary intervention (PCI) are associated with increased risk of post-PCI adverse outcomes.
Binita Shah+10 more
semanticscholar +1 more source
Supplemental Digital Content is available in the text. Background: In patients presenting with ST-segment–elevation myocardial infarction, percutaneous coronary intervention (PCI) reduces mortality when compared with fibrinolysis.
L. Chacko+12 more
semanticscholar +1 more source
Importance Data on P2Y12 inhibitor monotherapy after short-duration dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention are limited.
J. Hahn+28 more
semanticscholar +1 more source
Identification and management of patients at high bleeding risk undergoing percutaneous coronary intervention are of major importance, but a lack of standardization in defining this population limits trial design, data interpretation, and clinical ...
P. Urban+35 more
semanticscholar +1 more source
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction
Background The objective of the study was to identify any changes in primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in England by analysing procedural numbers, clinical characteristics and patient outcomes
C. Kwok+11 more
semanticscholar +1 more source